Previous 10 | Next 10 |
Are These Penny Stocks To Buy Right Now Or Avoid Entirely? If you’re looking for penny stocks to buy right now, this article discusses three companies that Wall Street analysts have hefty expectations for. While these are some of the most volatile types of companies to trade,...
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug for the treatment of major depressive disorder after r...
MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference Canada NewsWire NEW YORK , Oct. 5, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (...
A volatile stock even by the standards of the ever-seesawing biotech sector, Mind Medicine (NASDAQ: MNMD) -- also known as MindMed -- had a good session on the market Tuesday. On some good news from the lab, the clinical-stage company's stock rocketed to a nearly 6% gain on the day....
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA Canada NewsWire - Study will compare the acute subjective, physiological, and endocrine effects of R-MDMA, S-MDMA, and racemic MDMA in 24 healthy subjects - NEW YORK , ...
We have seen interest in psychedelics grow these last few years as societal attitudes toward the use of these drugs change and their purported benefits for mental-health conditions make headlines. While learning more about this topic and the advancements being made is interesting, it is ...
In sharp contrast to a diving S&P 500 index, Mind Medicine (NASDAQ: MNMD) stock rose on Thursday. Shares of the psychedelic-medicine developer reversed course from Wednesday, increasing by more than 6%, as a major investor strongly pushed back against a large planned seconda...
Why The Stock Market Is Down Today But wait, the stock market crash is over. At least, that is what some retail traders thought after yesterday’s broad-sector bounce led by tech. Waking up to the stock market today painted a much different picture. Even with this as the case, in ...
MindMed Board is Trippin': Significant Investor Calls for Termination of Highly Dilutive Equity Offering and Pledges to Hold Board and Management Accountable through Activist Campaign PR Newswire Investors States Shareholder Requisition of Special Meeting to Effect Sig...
Shares of Mind Medicine (NASDAQ: MNMD) , also known as MindMed, had crashed by 49.3% as of 12:08 p.m. ET Wednesday. The steep decline came after the clinical-stage biopharmaceutical company announced the pricing of its latest public offering. MindMed plans to sell 7,058,823 comm...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...